MedTrace Logo

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

NCT05765487 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-09-04

No results posted yet for this study

Summary

The goal of this clinical trial is to compare thermography images in normal healthy premenopausal women after the application of Sildenafil Cream, 3.6%, L-arginine cream, and placebo cream. Participants will be shown a series of explicit videos to elicit a change in genital temperature before and after application of cream.

Conditions

  • Sexual Arousal Disorder

Interventions

DRUG

Sildenafil

Sildenafil Cream, 3.6%

DRUG

Vehicle

No Active or experimental ingredients

DRUG

Placebo

Cream with only L-arginine

Sponsors & Collaborators

  • Strategic Science & Technologies, LLC

    collaborator INDUSTRY

  • Daré Bioscience, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-13
Primary Completion
2024-01-26
Completion
2024-10-21
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05765487 on ClinicalTrials.gov